GetTopicDetailResponse(id=3d9e1532650, topicName=Reparixin, introduction=Reparixin, content=null, image=null, comments=1, allHits=690, url=https://h5.medsci.cn/topic?id=15326, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=59136, tagList=[TagDto(tagId=59136, tagName=Reparixin)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1793188, encodeId=2b9b1e93188dd, content=<a href='/topic/show?id=3d9e1532650' target=_blank style='color:#2F92EE;'>#Reparixin#</a>, objectTitle=CLIN CANCER RES：Reparixin聯(lián)合紫杉醇治療HER-2陰性轉(zhuǎn)移性乳腺癌, objectType=article, longId=113409, objectId=4f6a11340907, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f6a11340907, replyNumber=0, likeNumber=72, createdTime=2018-07-02, rootId=0, userName=12498adam40暫無昵稱, userId=f07c2500133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f6a11340907, moduleTitle=CLIN CANCER RES：Reparixin聯(lián)合紫杉醇治療HER-2陰性轉(zhuǎn)移性乳腺癌, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=4f6a11340907)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
